Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2012-08-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Exercise, Dietary Counseling and Cognitive Behavioral Training as a Combined Intervention to Reduce Weight and Increase Workability in Health Care Workers
NCT01015716
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
NCT01585480
Multi-component Workplace Energy Balance Intervention
NCT02561611
Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss
NCT01461382
Office Worker Behavior and Health Study
NCT04042610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The WorkStation Intervention Group will be asked to walk for up to 1.5 hours per day during the work week of Monday through Friday on the treadmill. Participants will complete two sessions per day for up to 45 minutes per session, tracking time and speed.
Usual Working Condition Group will be asked to continue working in usual environment and accustomed manner.
Regardless of which group the participants are assigned to, the participants will be asked to complete baseline and follow up assessment visits. Months 3 and 6 for approximately 1 hour for Body measurements (height, weight and waist circumference), body fat percent, gait speed, questionnaires, and accelerometry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Working Condition Group
Participants assigned to the usual working condition control group will continue to work in their usual environment and accustomed manner. The control group participants will have access to the Workstations at the completion of study.
Usual Working Condition
Participants will be asked to continue working at their desk in their usual manner.
WorkStation Intervention Group
Participants will be asked to walk for up to 1.5 hours per day on the treadmill. This will be split into two 45 minute sessions per day. Behavioral support will focus on adherence to frequency (attending scheduled sessions). Participants self-select speed of walking and time (they have up to 45 minutes allotted, but may choose less as they like).
WorkStation
Participants will be asked to attend 2 scheduled sessions per day of treadmill walking, which will replace their sitting desk time. Participants will complete 2 sessions per day for 6 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WorkStation
Participants will be asked to attend 2 scheduled sessions per day of treadmill walking, which will replace their sitting desk time. Participants will complete 2 sessions per day for 6 months.
Usual Working Condition
Participants will be asked to continue working at their desk in their usual manner.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥ 25 kg/m2
* Willing to give informed consent
* Willing to accept randomization to group assignment and willing to follow the protocol for the group to which they have been assigned
* Willing to maintain fulltime employment at the company for the next 6 months
* Willing to receive frequent contacts and communication from study staff over the next 6 months
Exclusion Criteria
* BMI \< 25 kg/m2
* Type 1 diabetes
* Average step count of ≥ 7,500 steps/day
* Self-reporting exercising \> 20 minutes on 3 or more days/wk, within the past 6 months
* Unable to walk 45 minutes continuously without taking a rest
* Unable to walk without the use of an assistive device, such as a cane or walker
* Have had a cardiovascular event (stroke or heart attack) in the past 6 months
* Have a pacemaker or any other internal electrical medical device
* Have been diagnosed with Schizophrenia or bipolar disorder
* Have any condition that would limit participation in a physical activity program
* Women who are pregnant, have been pregnant in the last 6 months, or are breastfeeding
* Actively participating in a weight loss program
* Plan to move out of the study area within the next 6 months or plan to be away from work for more than 4 weeks in the next 6 months
* Have another member of household participating in the study
* Have any condition, which, in the opinion of the investigator would impede competence or compliance or possibly hinder completion of the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catrine Tudor-Locke, PhD
Role: PRINCIPAL_INVESTIGATOR
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 12015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.